Port-a-Cath® extravasation of vesicant cytotoxics: Surgical options for a rare complication of cancer chemotherapy
- 4 December 2014
- journal article
- Published by Elsevier BV in European Journal of Surgical Oncology
- Vol. 41 (3), 378-385
- https://doi.org/10.1016/j.ejso.2014.11.042
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Extravasation Injuries in AdultsISRN Dermatology, 2013
- Management of Cytotoxic Extravasation - ASORS Expert Opinion for Diagnosis, Prevention and TreatmentOncology Research and Treatment, 2013
- Subcutaneous wash-out procedure (SWOP) for the treatment of chemotherapeutic extravasationsJournal of Plastic, Reconstructive & Aesthetic Surgery, 2011
- Hydrothorax due to extravasation of intravenous contrast through left subclavian catheter -A case report-Korean Journal of Anesthesiology, 2010
- Complications associated with the use of Port-a-Caths in patients with malignant or haematological disease: a single-centre prospective analysisEuropean Journal of Cancer Care, 2009
- Managing Vesicant ExtravasationsThe Oncologist, 2008
- Retrospective Study of the Management of Chemotherapeutic Extravasation InjuryAnnals of Plastic Surgery, 2002
- Mediastinal infusion of epirubicin and 5-fluorouracil. A complication of totally implantable central venous systems. Report of a caseZeitschrift für Krebsforschung und Klinische Onkologie, 1996
- Comparison of a Totally Implantable Access Device for Chemotherapy (Port-A-Cath) and Long-term Percutaneous Catheterization (Broviac)*Southern Medical Journal, 1988
- Cancer chemotherapy agent-induced perivenous extravasation injuriesPublished by Oxford University Press (OUP) ,1987